Abstract: In some implementations, a computer-implemented method includes obtaining, by a computer system, cellular data from a real time cell analyzer; selecting one or more samples from the cellular data; identifying, for each of the one or more samples or for the cellular data as a whole, waypoints that define an analysis window; determining, by the computer system using cellular data from the analysis window, results for each of the one or more samples based on one or more metrics; and providing, by the computer system, information that identifies at least a portion of the results for the one or more samples.

Abstract: This document provides methods and materials for identifying prostate cancer patients likely to respond to an androgen deprivation therapy. For example, methods and materials for identifying a prostate cancer patient likely to respond to an androgen deprivation therapy based at least in part on the presence of a genetic variation in a TMRT11 nucleic acid are provided. This document also provides methods and materials for identifying prostate cancer patients likely to survive prostate cancer related death for a short or long period of time. For example, methods and materials for identifying a prostate cancer patient likely to survive prostate cancer related death for a short or long period of time based at least in part on the presence of a genetic variation in a UGT1A3 nucleic acid, a UGT1A7 nucleic acid, and/or a UGT1A10 nucleic acid are provided.